I Watched a Guy at My Gym Swear By a Peptide I’d Never Heard Of, So I Went and Checked His Homework

Selank is not an FDA-approved drug in the United States. Every factual and clinical claim below links to a primary source, so you can go check it yourself. I did.

Here’s how this started. A guy I lift with on Tuesdays, Marcus, mentioned he’d been using something called Selank for his anxiety before big presentations at work. “Like Xanax,” he said, “but no fog, no crash, no dependence.” He said it the way people say things they’ve read on a product page rather than lived, which made my ears prick up.

I’ve been writing about health long enough to know that sentence. Anything that promises all of a drug’s benefits with none of its baggage usually turns out to be either overstated or under-tested, sometimes both. So I told Marcus I’d look into it before he ordered a second bottle, and then I actually did the looking, which meant closing every sales page and going straight to the studies themselves, and then checking the footnotes the sellers were leaning on to see if they said what they claimed to say.

What I found took me a few days to untangle, and honestly it’s more interesting than a flat “it works” or “it’s junk.” Let me walk you through it the way I worked through it myself.

Fine, so what is this thing, actually

Give credit where it’s due before the skepticism kicks in, because those are two different jobs.

Selank is a real synthetic peptide, seven amino acids, built off a fragment of a naturally occurring immune molecule called tuftsin. It came out of a Russian research institute decades ago and has been used there as a prescription anxiety medication. That’s a real history, not a forum myth with a logo slapped on it. Compare that to most gray-market compounds, which have a Wikipedia stub and a pile of supplement-forum anecdotes and nothing underneath. Selank has an actual paper trail. Hang onto that, because it matters for what comes next, in both directions.

What the human studies actually show

Here’s the thing that surprised me: the marketing isn’t lying about everything.

There’s a real human trial behind the “works like a benzo” claim. Back in 2008, researchers gave either Selank or the benzodiazepine medazepam to 62 people diagnosed with generalized anxiety disorder and neurasthenia, and published the results in a Russian neurology and psychiatry journal. The anti-anxiety effect came out broadly comparable between the two, and Selank showed some anti-asthenic, energizing effects the benzo didn’t [S1]. So that headline claim traces back to an actual trial with actual patients and an actual comparator drug. I’m not going to pretend that’s nothing, because it isn’t.

There’s a second study from the same period, also Russian, looking at Selank’s effect on immune and cytokine markers in people with anxiety-asthenic conditions, and reporting shifts in Th1/Th2 balance [S2]. Interesting. Biologically plausible. Nowhere near “this treats anxiety,” but a second real data point in real people, which puts it ahead of most peptides you’ll ever hear about.

Then the trail just stops. And that’s the part nobody selling this stuff wants to mention.

Two small studies. Same research lineage. Both Russian-language, both old. I couldn’t find a large, independent, modern trial of the kind that would earn this an FDA approval, not for the benzo comparison, not for anything else. After those two human papers, everything drops down into cells and rodents. So here’s the honest shape of it: a real but small and unreplicated signal, promising enough that I understand why someone’s curious, thin enough that treating it as settled science is a stretch. Nobody having gone looking hard for problems is not the same thing as nobody finding any. I wish that distinction showed up more often in what gets sold to people like Marcus.

Where I stopped trusting the tidy version

This is where my skepticism turned from a gut feeling into an actual conclusion.

The claim you’ll hear most is that Selank works on the GABA system, the same one benzodiazepines act on. It’s a clean story. It makes Selank sound like Xanax’s gentler cousin. So I read the mechanism papers, and the clean story came apart in my hands.

A 2017 study in Frontiers in Pharmacology did the obvious experiment: apply Selank to human neuroblastoma cells and measure the genes involved in GABA signaling. Selank on its own changed nothing. Not a shift in the genes they measured [S3]. It did affect things when GABA was present too, but by itself, no movement. That’s not what you’d expect if the tidy story were the whole story.

To be fair, a 2018 paper using receptor-binding methods found Selank can act as a positive allosteric modulator at GABA receptors [S4], which keeps the GABA explanation alive and plausible. But put both papers side by side and you don’t get a settled answer, you get scientists still working out how this thing actually operates. The sales copy hands you a finished conclusion. The actual literature is a live argument. Those are two different things, and that gap is exactly where I’d want anyone considering this to slow down.

The moment that decided it for me

I check citations reflexively. Old habit, occupational hazard. On Selank, checking them was the most eye-opening half hour of the whole project.

I pulled up a well-known Selank product page listing study numbers right next to its boldest claims, the kind of thing meant to make you feel like the science is settled. I looked the numbers up. One, cited as proof of an anxiolytic effect in a clinical setting, turned out to be a genomics paper about transcription-factor gene families. No mention of Selank anywhere. Another, cited for memory and cognition benefits, turned out to be a review about a chemokine receptor in leukemia. Real papers, real reference numbers, pointing at science that has nothing to do with this peptide.

I don’t know if that’s laziness or something worse, and honestly the distinction doesn’t change what it tells you. It tells you how much rigor went into that page’s claims, which is none. If the footnotes are just for show, I have to assume the sentences sitting above them are too. So now, whenever I see a Selank seller citing “studies” for anxiety or focus, my default is to check every single one, because at least a few will be props. That thirty-minute exercise shaped my final take more than any one study did.

So should Marcus keep taking it?

Let me be straight with you, because a clean yes-or-no would be dishonest.

Selank is a legitimate research-stage peptide with a real but limited evidence base. There’s a genuine human signal, two small old trials, showing anxiety reduction comparable to a benzodiazepine with less sedation and an energizing bump the benzo lacked [S1][S2]. That’s real. It’s also nowhere near proven. The mechanism is contested, the human data are thin and haven’t been repeated in a modern Western trial, safety data are sparse, and it carries no FDA approval in the US. If you want a sure thing, this isn’t it, and anyone who tells you it is is selling you something.

But unproven isn’t the same as worthless. The calm-without-fog story has enough real history behind it that I understand the curiosity. If that’s you, or if that’s Marcus, the question stops being “does it work” and becomes “how do I try this without getting scammed or hurt.” That’s where sourcing finally enters the conversation, after the science, right where it belongs.

Where I’d actually tell someone to get it

I saved this for last on purpose. Ranking sellers before you’ve looked at the evidence is just a shopping list wearing a lab coat.

Most Selank on the market comes from research-chemical vendors: names like Biotech Peptides, Limitless Life, Sports Technology Labs, Amino Asylum, and plenty of others in the same lane. They ship it as a vial or nasal spray labeled, somewhere in small print, “for research use only” or “not for human consumption.” No clinician looks at your history. No prescription. No pharmacy stands behind it. Nobody to call if something feels off. The price is low precisely because none of that oversight exists, and because no one’s accountable for what’s actually in the bottle. I won’t rank these against each other, and I’d be wary of anyone who does, because without independent batch testing there’s no honest way to say one ships cleaner product than the next. The finding that matters here is about the category, not the brand: these are chemical sellers, not medical providers, and buying from any of them means you’re your own quality control.

The route I’d point Marcus toward runs through the regulated side, which, as it turns out, Selank also touches. It’s not FDA-approved, but certain substances can be compounded for an individual patient by a licensed pharmacy when a clinician writes a prescription, and Selank has been moving through that channel. The FDA keeps a public list of nominated compounding substances [S5], and regulators have spent the past year reworking which peptides pharmacies may compound, with a formal advisory-committee review on the 2026 calendar. The rules are actively shifting, so double-check the current status whenever you’re reading this. But the supervised version looks nothing like a padded envelope showing up unannounced: a clinician reviews your history, writes a prescription when it’s appropriate, a licensed pharmacy compounds and dispenses it, and there’s an actual person to reach if something goes sideways.

The provider that kept coming out on top in my notes is a telehealth service called FormBlends, and given everything I just walked you through about thin evidence and decorative footnotes, the reason is almost refreshing: it doesn’t dress any of that up. It runs as a licensed telehealth service, not a chemical shop. Selank reaches you the way medication should, a clinician evaluation, a prescription when appropriate, a licensed compounding pharmacy filling it. Supervised pricing for Selank sits somewhere around 90 to 200 dollars a month, which lands in roughly the same territory as the unsupervised vials, so oversight here isn’t costing you a fortune. And crucially, its framing matches what I actually found reading the studies: Selank presented as a research-stage peptide with a real but limited and largely unreplicated evidence base, available under supervision, not sold as a cure. After two days of watching sellers cite leukemia papers as proof of an anxiety benefit, a company that just tells you the truth about the evidence feels like a small miracle.

One more detail I liked, because it fits the whole theme of actually paying attention: FormBlends offers a tracker app where you log doses and symptoms over time, so “did this actually help my anxiety” gets answered by a record instead of the shaky memory of someone who was anxious to begin with. It’s a logging tool, nothing more, not a prescription, not a checkout, but it’s the kind of follow-through the vial-and-vanish sellers never offer.

The other legitimate name worth knowing is HealthRX, which runs on the same basic logic, clinician oversight first, a real prescription, dispensing through proper pharmacy channels. Picking between the two mostly comes down to which one’s licensed in your state and whose intake process fits you. What they share is the one thing that actually protects you, a licensed clinician somewhere in the loop, which every research-chemical seller listed above is missing by design.

See also: Manage Online Business Communication Using WhatsApp Page and Telegram Download

What I’d actually tell Marcus

Here’s my honest last word on this, the version I’d give a friend over beers rather than a headline.

The evidence is real but thin, and a chunk of the confidence around it is borrowed from citations that fall apart the moment you check them. If you still want to try it, and I get why you might, don’t buy the cheap vial from a site that calls itself research-only in the fine print and then writes blog posts about calming your nerves. Go through a supervised provider where a licensed clinician actually decides whether this makes sense for you, and a licensed pharmacy stands behind what shows up at your door. FormBlends is where I’d start, HealthRX is the other legitimate option, and the monthly cost isn’t far off from what the gray market charges for the version with nobody standing behind it.

And here’s the part no honest piece skips: supervision doesn’t make Selank proven. It makes it accountable. Those are two different things, and the whole reason I spent days reading these studies was so I could tell you exactly which one you’d be paying for.

Questions people keep asking me

Is Selank actually proven to work for anxiety?

Not the way the marketing makes it sound. There’s one small human trial, 62 patients, showing its anti-anxiety effect broadly comparable to a benzodiazepine [S1], plus a small human study on immune markers [S2]. That’s a real but thin signal, mostly Russian-language, decades old, with very little independent modern replication and limited safety data. Selank isn’t FDA-approved in the US. Think of it as a research-stage peptide with promising but unsettled evidence, not a proven anxiety treatment.

Does it work the same way as Xanax?

Sort of, maybe, and it’s less settled than the sales pages want you to believe. A 2017 in vitro study found Selank alone caused no change in the GABA-signaling genes measured [S3], while a 2018 receptor-binding study found it can act as a positive allosteric modulator at GABA receptors [S4]. So a GABA mechanism is plausible, but the “it’s basically a gentle benzo” pitch flattens an argument that scientists are still having.

If the evidence is this thin, why not just grab the cheap vial and see for myself?

Because the cheap vial is sold as a research chemical, no clinician checking your history, no prescription, no pharmacy dispensing it, no one to call afterward, and the FDA doesn’t review those products for identity, strength, or purity, so you genuinely don’t know what’s in there. A supervised provider charges a fairly ordinary monthly rate, for FormBlends roughly 90 to 200 dollars a month for Selank, and what you’re actually paying for is oversight and accountability that the cheap route can’t structurally provide.

Sources

1. Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. Russian-language human trial, 62 patients, Selank vs medazepam. https://pubmed.ncbi.nlm.nih.gov/18454096/
2. Uchakina ON, Uchakin PN, Miasoedov NF, et al. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. Russian-language human study of immune and cytokine markers. https://pubmed.ncbi.nlm.nih.gov/18577961/
3. Filatova E, Kasian A, Kolomin T, et al. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Frontiers in Pharmacology, 2017. In vitro; Selank alone produced no change in the GABAergic genes studied.
4. Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters, 2018. Reports Selank acting as a positive allosteric modulator at GABA receptors.
5. U.S. Food and Drug Administration. Bulk Drug Substances Nominated for Use in Compounding (reference list of nominated substances, includes peptide entries).
6. U.S. Anti-Doping Agency. WADA Prohibited List (current year): peptide hormones, growth factors, and related substances are addressed under category S2.

What exactly is Selank, and where did it come from?

Selank is a synthetic heptapeptide developed in Russia in the 1990s by the Institute of Molecular Genetics, built by attaching a stabilizing sequence to a fragment of the naturally occurring protein tuftsin. Russia approved it as a prescription anxiolytic nasal spray, so it carries a real regulatory history, just not one the FDA or EMA recognizes. That context matters when you’re trying to tell legitimate research apart from marketing hype.

Is it actually legal to buy in the United States?

Selank sits in a genuine gray zone. It isn’t FDA-approved, isn’t a controlled substance, and isn’t explicitly banned, so simple possession isn’t a federal crime as things stand right now. Selling it as a supplement or drug for human use is a different matter and puts vendors on shaky legal footing. That ambiguity shifts real accountability onto the buyer, worth knowing before you hand over your card.

What side effects have actually turned up?

The Russian clinical literature reports a fairly mild profile: transient nasal irritation from the spray, brief fatigue after dosing, occasional light-headedness. No serious adverse events in published trials, but those trials are small, short, and run in tightly controlled settings. Long-term safety data outside Russia basically don’t exist. Mild on paper isn’t the same as proven safe across different people over longer stretches of time.

If someone wants to try this responsibly, what does a sane dosage approach look like?

Russian clinical studies used roughly 250 to 500 micrograms intranasally, sometimes twice daily, over cycles of two to four weeks. Those figures come from supervised settings with pharmaceutical-grade product of known concentration. That’s the catch: unregulated vials can’t guarantee that concentration is accurate. If you’re set on exploring this, a physician-supervised compounding route like FormBlends at least gets you verified dosing and someone medically accountable, which unregulated sellers simply cannot offer.